English Journal
- [Developmental dysphasia: assessment of the drug treatment efficacy].
- Zavadenko NN, Kozlova EV, Koltunov IE.AbstractTo assess the efficacy of treatment with encephabol, we examined 40 children, aged from 3 to 5 years, with developmental dysphasia. All patients were randomized into two equal groups: group 1 received encephabol (suspension form, daily dosage 200-250 mg, or 12-15 mg/kg) during 2 months; group 2 did not receive this medication. In the first group, there was a significant improvement of expressive and impressive speech and speech attention; the active vocabulary and a number of phrases in colloquial speech increased by a factor of 3 versus 1.5 in the control group. After the treatment with encephabol, the parents reported the decrease in motor disturbances, psychosomatic disorders, the improvement of attention and the emotional state of the children.
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov.Zh Nevrol Psikhiatr Im S S Korsakova.2012;112(7 Pt 2):90-5.
- To assess the efficacy of treatment with encephabol, we examined 40 children, aged from 3 to 5 years, with developmental dysphasia. All patients were randomized into two equal groups: group 1 received encephabol (suspension form, daily dosage 200-250 mg, or 12-15 mg/kg) during 2 months; group 2 did
- PMID 23330199
- [Efficacy of cortexin in the treatment of memory disorders in children].
- Chutko LS, Surushkina SIu, Iakovenko EA, Bykova IuL, Nikishena IS.AbstractChildren, aged from 7 to 12 years, with memory disorders were treated with cortexin (30 patients) and encephabol (30 patients). The comparative evaluation of efficacy and safety of these drugs was carried out. The higher cortexin efficacy (the improvement in 86.7% of cases) in comparison with encephabol (the improvement in 63.3% of cases) confirmed by the data of neuropsychological and neurophysiological research is established.
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov.Zh Nevrol Psikhiatr Im S S Korsakova.2011;111(9 Pt 2):37-40.
- Children, aged from 7 to 12 years, with memory disorders were treated with cortexin (30 patients) and encephabol (30 patients). The comparative evaluation of efficacy and safety of these drugs was carried out. The higher cortexin efficacy (the improvement in 86.7% of cases) in comparison with enceph
- PMID 22027605
- [Encephabol in the treatment of cognitive disorders in epilepsy].
- Zenkov LR, Zenkova AL.AbstractCognitive disorders in patients with epilepsy were studied before and after the 6-week treatment with encephabol. The data on the examination of 24 patients were summarized. Before the treatment, patients with epilepsy demonstrated a larger number of errors, lower speed of reading and worse learning of the content compared to the controls (18 healthy people). Encephabol was prescribed in dosage 600 mg/day to people over 12 years of age and in dosage 300-400 mg/day to people younger than 12 years. The statistically significant improvement of the global self-rating of cognitive functions, speed of reading, decrease of errors as well as learning of the content were seen after the end of treatment. The improvement of cognitive traits was correlated with the improvement of computed EEG parameters (the decrease of delta power in the right temporal and frontal regions). Encephabol did not lead to the increase of epileptiform activity in the EEG. No increase in the number and severity of seizures was noted. In conclusion, encephabol may be used in treatment of cognitive disorders in epilepsy.
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov.Zh Nevrol Psikhiatr Im S S Korsakova.2011;111(5 Pt 2):77-80.
- Cognitive disorders in patients with epilepsy were studied before and after the 6-week treatment with encephabol. The data on the examination of 24 patients were summarized. Before the treatment, patients with epilepsy demonstrated a larger number of errors, lower speed of reading and worse learning
- PMID 23120794
Japanese Journal
- 舌に発現したペニシラミンによると思われるへん平苔せん型薬疹の１例
- 日本口腔科学会雑誌 42(2), 419-422, 1993
- NAID 130004335410
- Ｓｕｌｏｃｔｉｄｉｌの脳機能保護作用
- 日本薬理学雑誌 82(1), 37-46, 1983
- NAID 130000760577
- 薬しんの原因薬と臨床型
- 皮膚 24(5), 742-756, 1982
- NAID 130003843066
Related Links
- 必应词典为您提供pyrithioxine的释义，n. 脑复新；吡硫醇； 网络释义： 二乙吡啶二酮； Web Images Videos Maps News More Bing Rewards Sign in pyrithioxine US UK n. 脑复新；吡硫醇 Web 二乙吡啶二酮 E-C Web Definition n. ...
- Manufacturer and supplier of pyrithioxine, pyrithioxine hcl, pyrithioxine hydrochloride, pyrithioxine hydrochloride monohydrate, amoxicillin, hypolipidemic agent, hypolipidemic drug, l-2-aminobutanol, pyritinol, pyritinol hydrochloride ... ...
Related Pictures
★リンクテーブル★
| リンク元 | 「ピリチオキシン」「pyritinol」 |
| 拡張検索 | 「pyrithioxine hydrochloride」 |
| 関連記事 | 「pyrithioxin」 |